18F-FAPI

Fluorine-18 labeled fibroblast activation protein inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 18F-FAPI, covering 2024-08-14 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer